A missense mutation encoding cys67 → gly in neurophysin II is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus

Linda DiMeglio, Priscila C. Gagliardi, James E. Browning, Charmian A. Quigley, David R. Repaske

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) is an inherited disorder in which progressive degeneration of magnocellular neurons of the hypothalamus impairs production of arginine vasopressin (AVP). ADNDI is caused by mutations in the arginine vasopressin-neurophysin II (AVP-NPII) gene. These mutations are hypothesized to trigger neurodegeneration via disruption of preproAVP-NPII processing. Affected individuals usually develop diabetes insipidus between 1 and 6 years of age. Here we report a novel mutation of the AVP-NPII gene in a family with unusually early presentation of ADNDI. The index case developed symptoms of diabetes insipidus at 1 month of age, her mother at 9 months of age, and the maternal grandfather in early childhood. Each was found to be heterozygous for the missense mutation 1665T > G encoding the amino acid substitution C67G within NPII. This mutation helps to define two homologous regions of the AVP.NPII precursor bounded by disulfide bridges between C13 and C27 and between C61 and C73 that have structural homology and contain the majority of amino acid substitutions associated with ADNDI. The early onset of symptomatic diabetes insipidus in this family suggests that the C67G substitution may be particularly deleterious to magnocellular neurons and may provide a valuable model for study of dominantly inherited neurodegeneration.

Original languageEnglish
Pages (from-to)39-44
Number of pages6
JournalMolecular Genetics and Metabolism
Volume72
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Neurogenic Diabetes Insipidus
Neurophysins
Arginine Vasopressin
Missense Mutation
Medical problems
Diabetes Insipidus
Mutation
Amino Acid Substitution
Substitution reactions
Nerve Degeneration
Maternal Age
Neurons
Disulfides
Genes
Hypothalamus
Amino Acids
Mothers
Processing

Keywords

  • Arginine vasopressin
  • Autosomal dominant neurohypophyseal diabetes insipidus
  • Diabetes insipidus
  • Human
  • Magnocellular neuron
  • Mutation
  • Neurodegeneration
  • Neurophysin II

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

A missense mutation encoding cys67 → gly in neurophysin II is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus. / DiMeglio, Linda; Gagliardi, Priscila C.; Browning, James E.; Quigley, Charmian A.; Repaske, David R.

In: Molecular Genetics and Metabolism, Vol. 72, No. 1, 2001, p. 39-44.

Research output: Contribution to journalArticle

DiMeglio, Linda ; Gagliardi, Priscila C. ; Browning, James E. ; Quigley, Charmian A. ; Repaske, David R. / A missense mutation encoding cys67 → gly in neurophysin II is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus. In: Molecular Genetics and Metabolism. 2001 ; Vol. 72, No. 1. pp. 39-44.
@article{9aafb0df53d74a0b8ad62af5f61f2394,
title = "A missense mutation encoding cys67 → gly in neurophysin II is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus",
abstract = "Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) is an inherited disorder in which progressive degeneration of magnocellular neurons of the hypothalamus impairs production of arginine vasopressin (AVP). ADNDI is caused by mutations in the arginine vasopressin-neurophysin II (AVP-NPII) gene. These mutations are hypothesized to trigger neurodegeneration via disruption of preproAVP-NPII processing. Affected individuals usually develop diabetes insipidus between 1 and 6 years of age. Here we report a novel mutation of the AVP-NPII gene in a family with unusually early presentation of ADNDI. The index case developed symptoms of diabetes insipidus at 1 month of age, her mother at 9 months of age, and the maternal grandfather in early childhood. Each was found to be heterozygous for the missense mutation 1665T > G encoding the amino acid substitution C67G within NPII. This mutation helps to define two homologous regions of the AVP.NPII precursor bounded by disulfide bridges between C13 and C27 and between C61 and C73 that have structural homology and contain the majority of amino acid substitutions associated with ADNDI. The early onset of symptomatic diabetes insipidus in this family suggests that the C67G substitution may be particularly deleterious to magnocellular neurons and may provide a valuable model for study of dominantly inherited neurodegeneration.",
keywords = "Arginine vasopressin, Autosomal dominant neurohypophyseal diabetes insipidus, Diabetes insipidus, Human, Magnocellular neuron, Mutation, Neurodegeneration, Neurophysin II",
author = "Linda DiMeglio and Gagliardi, {Priscila C.} and Browning, {James E.} and Quigley, {Charmian A.} and Repaske, {David R.}",
year = "2001",
doi = "10.1006/mgme.2000.3117",
language = "English",
volume = "72",
pages = "39--44",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - A missense mutation encoding cys67 → gly in neurophysin II is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus

AU - DiMeglio, Linda

AU - Gagliardi, Priscila C.

AU - Browning, James E.

AU - Quigley, Charmian A.

AU - Repaske, David R.

PY - 2001

Y1 - 2001

N2 - Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) is an inherited disorder in which progressive degeneration of magnocellular neurons of the hypothalamus impairs production of arginine vasopressin (AVP). ADNDI is caused by mutations in the arginine vasopressin-neurophysin II (AVP-NPII) gene. These mutations are hypothesized to trigger neurodegeneration via disruption of preproAVP-NPII processing. Affected individuals usually develop diabetes insipidus between 1 and 6 years of age. Here we report a novel mutation of the AVP-NPII gene in a family with unusually early presentation of ADNDI. The index case developed symptoms of diabetes insipidus at 1 month of age, her mother at 9 months of age, and the maternal grandfather in early childhood. Each was found to be heterozygous for the missense mutation 1665T > G encoding the amino acid substitution C67G within NPII. This mutation helps to define two homologous regions of the AVP.NPII precursor bounded by disulfide bridges between C13 and C27 and between C61 and C73 that have structural homology and contain the majority of amino acid substitutions associated with ADNDI. The early onset of symptomatic diabetes insipidus in this family suggests that the C67G substitution may be particularly deleterious to magnocellular neurons and may provide a valuable model for study of dominantly inherited neurodegeneration.

AB - Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) is an inherited disorder in which progressive degeneration of magnocellular neurons of the hypothalamus impairs production of arginine vasopressin (AVP). ADNDI is caused by mutations in the arginine vasopressin-neurophysin II (AVP-NPII) gene. These mutations are hypothesized to trigger neurodegeneration via disruption of preproAVP-NPII processing. Affected individuals usually develop diabetes insipidus between 1 and 6 years of age. Here we report a novel mutation of the AVP-NPII gene in a family with unusually early presentation of ADNDI. The index case developed symptoms of diabetes insipidus at 1 month of age, her mother at 9 months of age, and the maternal grandfather in early childhood. Each was found to be heterozygous for the missense mutation 1665T > G encoding the amino acid substitution C67G within NPII. This mutation helps to define two homologous regions of the AVP.NPII precursor bounded by disulfide bridges between C13 and C27 and between C61 and C73 that have structural homology and contain the majority of amino acid substitutions associated with ADNDI. The early onset of symptomatic diabetes insipidus in this family suggests that the C67G substitution may be particularly deleterious to magnocellular neurons and may provide a valuable model for study of dominantly inherited neurodegeneration.

KW - Arginine vasopressin

KW - Autosomal dominant neurohypophyseal diabetes insipidus

KW - Diabetes insipidus

KW - Human

KW - Magnocellular neuron

KW - Mutation

KW - Neurodegeneration

KW - Neurophysin II

UR - http://www.scopus.com/inward/record.url?scp=0035715968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035715968&partnerID=8YFLogxK

U2 - 10.1006/mgme.2000.3117

DO - 10.1006/mgme.2000.3117

M3 - Article

C2 - 11161827

AN - SCOPUS:0035715968

VL - 72

SP - 39

EP - 44

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 1

ER -